ACHILLION PHARMACEUTICALS Aktie

5,39 EUR -2,2505%

Zu Ihrem Onlinebroker

kaufen verkaufen

ACHILLION PHARMACEUTICALS Aktienkurs : 23.05. ( 15 Min. verzögert)
5,39 € Letzter Kurs	-2,25% Veränderung	5,51 € Vortag	5,39 € Eröffnungskurs

Realtime:

5,39

-2,25%

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
5,39 - 5,39 Tag	9,83 - 2,99 52 Wochen	0 Tag	322 Ø 52 Wochen	5,51 2.200 Stücke	5,62 2.200 Stücke

ACHILLION PHARMACEUTICALS Akt…

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

23.05.

Did You Buy These Stocks?

Achillion Pharmaceuticals Inc.(ACHN) was trading around $4 when we alerted readers to the stock last October, and based on Tuesday's closing price of $6.93, it is up 58%. The stock set a 52-week …
21.05.

Achillion jumps on hepatitis C study

BOSTON (MarketWatch) -- Shares of Achillion Pharmaceuticals (US:achn) jumped 11% to $7.24 on Monday after the biotech group released a positive Phase I study on its hepatitis...

21.05.

Achillion Announces Additional Proof-of-Concept Data With ACH-2684 for the ...

NEW HAVEN, Conn., May 21, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported proof-of-concept data from a Phase 1b clinical trial demonstrating that patients with chronic hepatitis C (HCV)...
21.05.

Achillion Announces Additional Proof-of-Concept Data With ACH-2684 for the ...

NEW HAVEN, Conn., May 21, 2012 (GlobeNewswire via COMTEX) -- Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) today reported proof-of-concept data from a Phase 1b clinical trial demonstrating that patients with chronic hepatitis C (HCV)...
18.05.

Achillion Announces Executive Promotion

NEW HAVEN, Conn., May 18, 2012 (GlobeNewswire via COMTEX) -- Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) , a leader in the discovery and development of small molecule drugs to combat the most challenging infectious...